Cited by 176Cardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic ControlCardiovascular and exercise physiology

Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome

Open access
Fu, Qi, VanGundy, Tiffany B., Shibata, Shigeki, Auchus, Richard J., Williams, Gordon H., Levine, Benjamin D.·2011·Hypertension

Abstract

We have found recently that exercise training is effective in the treatment of the postural orthostatic tachycardia syndrome (POTS). Whether this nondrug treatment is superior to “standard” drug therapies, such as β-blockade, is unknown. We tested the hypothesis that exercise training but not β-blockade treatment improves symptoms, hemodynamics, and renal-adrenal responses in POTS patients. Nineteen patients (18 women and 1 man) completed a double-blind drug trial (propranolol or placebo) for 4 weeks, followed by 3 months of exercise training. Fifteen age-matched healthy individuals (14 women and 1 man) served as controls. A 2-hour standing test was performed before and after drug treatment and training. Hemodynamics, catecholamines, plasma renin activity, and aldosterone were measured supine and during 2-hour standing. We found that both propranolol and training significantly lowered standing heart rate. Standing cardiac output was lowered after propranolol treatment ( P =0.01) but was minimally changed after training. The aldosterone:renin ratio during 2-hour standing remained unchanged after propranolol treatment (4.1±1.7 [SD] before versus 3.9±2.0 after; P =0.46) but modestly increased after training (5.2±2.9 versus 6.5±3.0; P =0.05). Plasma catecholamines were not affected by propranolol or training. Patient quality of life, assessed using the 36-item Short-Form Health Survey, was improved after training (physical functioning score 33±10 before versus 50±9 after; social functioning score 37±9 versus 48±6; both P <0.01) but not after propranolol treatment (34±10 versus 36±11, P =0.63; 39±7 versus 39±5, P =0.73). These results suggest that, for patients with POTS, exercise training is superior to propranolol at restoring upright hemodynamics, normalizing renal-adrenal responsiveness, and improving quality of life.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.111.172262

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Treatments that improve symptoms of POTS might decrease the occurrence of syncope.

    “Treatments that improve symptoms of POTS might decrease the occurrence of syncope, although this is unknown (24,514–523).”

    From 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope (2017) · cites this paper as [517]

    The Results (Exercise Training; page unavailable) report improved quality of life and presyncope in three patients before training versus one afterward. The Discussion (Perspectives; page unavailable) says exercise improved POTS symptoms. Presyncope is not syncope, however, and the paper does not establish or explicitly propose that symptom-improving treatments decrease syncope occurrence. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Long-acting propranolol does not improve quality of life in POTS patients.

    “Long-acting propranolol does not improve the quality of life of patients with POTS,43”
  • Although long-acting propranolol has been demonstrated to reduce standing HR in POTS, this medication did not improve quality of life.

    “However, although long-acting propranolol has been demonstrated to reduce standing HR in POTS, this medication did not improve quality of life (98).”

    From Postural Orthostatic Tachycardia Syndrome (2019) · cites this paper as [98]

  • In a double-blind drug trial, propranolol was effective at reducing standing HR, but exercise training was superior to propranolol at restoring upright hemodynamics and normalizing renal-adrenal responsiveness.

    “Even though propranolol was also effective at reducing standing HR, exercise training was found to be superior to propranolol at restoring upright hemodynamics and normalizing renal-adrenal responsiveness.”

    From Postural Orthostatic Tachycardia Syndrome (2019) · cites this paper as [98]

  • Patient quality of life improved after exercise training but not with propranolol treatment.

    “Patient quality of life also improved after exercise training, but not with propranolol treatment (98).”

    From Postural Orthostatic Tachycardia Syndrome (2019) · cites this paper as [98]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 45 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Fu, Q., VanGundy, T. B., Shibata, S., Auchus, R. J., Williams, G. H., & Levine, B. D.
Affiliations
Brigham and Women's Hospital (US)
Venue
Hypertension
Published
2011-08
Volume
58
Issue
2
Pages
167-175
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2150733776
Cited by
175
References
45
Citations by year
2026: 9 · 2025: 15 · 2024: 13 · 2023: 17 · 2022: 13 · 2021: 10 · 2020: 15 · 2019: 12 · 2018: 7 · 2017: 11 · 2016: 8 · 2015: 6 · 2014: 15 · 2013: 10 · 2012: 11
FWCI
12.45
Type
journal article
Language
en
Open access
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Heart, Lung, and Blood Institute (HL075283, K23HL075283)
  • National Cancer Institute (CA00701)
  • National Center for Research Resources (RR 00633, M01RR000633)
Topics
  • Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
Keywords
postural orthostatic tachycardia syndrome, exercise training, propranolol, beta-adrenergic blockade, aldosterone, plasma renin activity, catecholamines, cardiac output, hemodynamics, quality of life, non-pharmacological treatment
MeSH terms
Adrenergic beta-Antagonists, Adult, Aldosterone, Blood Pressure, Double-Blind Method, Exercise Therapy, Female, Health Surveys, Heart Rate, Hemodynamics, Humans, Male, Propranolol, Quality of Life, Renin, Treatment Outcome, Postural Orthostatic Tachycardia Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review